Intelligence Platform

Patents

Browse 20 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 11891638

Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

Northwestern University · Granted Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11447521

Compounds and methods for modulating angiotensinogen expression

Ionis Pharmaceuticals, Inc. · Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11419942

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11078471

Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

Northwestern University · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10912792

Compounds and methods for modulating angiotensinogen expression

Ionis Pharmaceuticals, Inc. · Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10814007

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10709728

Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10443049

Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

Northwestern University · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10238749

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670473

Crystals of angiotensin-converting enzyme (ACE)

ANGIODESIGN (UK) LIMITED · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387249

Methods of treating hypertension with at least one angiotensin II receptor blocker and chl

Takeda Pharmaceutical Company Limited · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895755

Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having ang

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569351

Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor an

Theravance, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378108

Percutaneous absorption preparation of compound having angiotensin II antagonistic activit

Takeda Pharmaceutical Company Limited · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6521659

Compositions containing a substituted indolealkanoic acid and an angiotensin converting en

The Institute for Pharmaceutical Discovery, LLC · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6420405

Pharmaceutical composition for angiotensin II-mediated diseases

Takeda Chemical Industries Ltd. · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6348481

Pharmaceutical composition for angiotensin II-mediated diseases

Takeda Chemical Industries Ltd. · Granted Tue Feb 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6228874

Pharmaceutical composition for angiotensin II-mediated diseases

Takeda Chemical Industries Ltd. · Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194460

Composition for treating cough induced by angiotensin converting enzyme inhibitors

Montefiore Medical Center · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6100252

Heterocyclic compounds and their use as angiotensin antagonists

Takeda Chemical Industries Ltd. · Granted Tue Aug 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired